ArticleWorld journal of gastrointestinal surgery2026
Efficacy of endoscopic submucosal dissection in the treatment of early gastrointestinal lesions.
Article in World journal of gastrointestinal surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndoscopic submucosal dissection (ESD) is applicable to early-stage gastrointestinal cancers, but its role in early gastrointestinal lesions is insufficiently researched.
aimTo evaluated the efficacy and safety profile of ESD compared with conventional gastrectomy for managing early gastrointestinal lesions, emphasizing clinical outcomes and postoperative recovery.
methodsA retrospective review was conducted on 206 patients diagnosed with early-stage gastrointestinal lesions at the Affiliated Hospital of North Sichuan Medical College between June 2021 and June 2024. Patients were divided into two groups: 98 underwent gastrectomy and 108 received ESD. Outcomes assessed included overall treatment efficacy, postoperative complications, serum tumor marker levels, gastrointestinal hormone concentrations, and mucosal barrier integrity indices.
resultsThe ESD group showed higher overall treatment efficacy (98.15%
conclusionFor early gastrointestinal lesions, ESD represents a safe and effective alternative to conventional gastrectomy. It enables precise lesion excision with fewer complications and faster postoperative recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.